Analystreport

Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.

EyePoint Pharmaceuticals, Inc.  (EYPT) 
Last eyepoint pharmaceuticals, inc. earnings: 3/5 07:00 am Check Earnings Report